USD 0.01
(0.0%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2022 | 1.31 Million CAD | 2392.97% |
2021 | -57.17 Thousand CAD | 93.09% |
2020 | -826.9 Thousand CAD | -568.5% |
2019 | 176.5 Thousand CAD | 903.49% |
2018 | -21.96 Thousand CAD | 42.77% |
2017 | -38.38 Thousand CAD | 74.57% |
2016 | -150.97 Thousand CAD | 38.45% |
2015 | -245.28 Thousand CAD | -2004.75% |
2014 | -11.65 Thousand CAD | -52.88% |
2013 | -7623.00 CAD | 2.93% |
2012 | -7853.00 CAD | -102.87% |
2011 | 273.84 Thousand CAD | 422.46% |
2010 | 52.41 Thousand CAD | 165.75% |
2009 | -79.71 Thousand CAD | -370.08% |
2008 | 29.51 Thousand CAD | 117.74% |
2007 | -166.36 Thousand CAD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 Q1 | 1.39 Million CAD | 6.49% |
2023 Q3 | 1.58 Million CAD | 9.55% |
2023 Q2 | 1.44 Million CAD | 3.5% |
2022 Q2 | 475.97 Thousand CAD | 253077.66% |
2022 Q1 | 188.00 CAD | 100.33% |
2022 FY | 1.31 Million CAD | 2392.97% |
2022 Q4 | 1.31 Million CAD | 6.05% |
2022 Q3 | 1.23 Million CAD | 159.73% |
2021 Q2 | -234.77 Thousand CAD | 72.57% |
2021 Q3 | -304.00 CAD | 99.87% |
2021 Q4 | -57.17 Thousand CAD | -18708.22% |
2021 FY | -57.17 Thousand CAD | 93.09% |
2021 Q1 | -855.84 Thousand CAD | -3.5% |
2020 Q2 | -3857.00 CAD | 95.36% |
2020 Q1 | -83.09 Thousand CAD | -147.08% |
2020 FY | -826.9 Thousand CAD | -568.5% |
2020 Q4 | -826.9 Thousand CAD | -385.01% |
2020 Q3 | -170.49 Thousand CAD | -4320.35% |
2019 Q1 | -81.06 Thousand CAD | -269.02% |
2019 FY | 176.5 Thousand CAD | 903.49% |
2019 Q4 | 176.5 Thousand CAD | 2636.69% |
2019 Q3 | -6958.00 CAD | 30.2% |
2019 Q2 | -9969.00 CAD | 87.7% |
2018 Q3 | 2.36 Million CAD | 147.7% |
2018 Q1 | 1.28 Million CAD | 3455.93% |
2018 FY | -21.96 Thousand CAD | 42.77% |
2018 Q4 | -21.96 Thousand CAD | -100.93% |
2018 Q2 | 955.04 Thousand CAD | -25.86% |
2017 Q3 | -60.43 Thousand CAD | 34.32% |
2017 Q2 | -92 Thousand CAD | 22.12% |
2017 Q1 | -118.13 Thousand CAD | 21.75% |
2017 Q4 | -38.38 Thousand CAD | 36.48% |
2017 FY | -38.38 Thousand CAD | 74.57% |
2016 Q3 | -171.34 Thousand CAD | 10.02% |
2016 FY | -150.97 Thousand CAD | 38.45% |
2016 Q4 | -150.97 Thousand CAD | 11.89% |
2016 Q2 | -190.42 Thousand CAD | 15.07% |
2016 Q1 | -224.2 Thousand CAD | 8.6% |
2015 Q2 | -7158.00 CAD | 16.84% |
2015 Q3 | -239.62 Thousand CAD | -3247.64% |
2015 Q4 | -245.28 Thousand CAD | -2.36% |
2015 FY | -245.28 Thousand CAD | -2004.75% |
2015 Q1 | -8607.00 CAD | 26.15% |
2014 Q3 | -7277.00 CAD | -10.93% |
2014 Q2 | -6560.00 CAD | -18.88% |
2014 Q1 | -5518.00 CAD | 27.61% |
2014 Q4 | -11.65 Thousand CAD | -60.15% |
2014 FY | -11.65 Thousand CAD | -52.88% |
2013 Q1 | -9861.00 CAD | -25.57% |
2013 Q4 | -7623.00 CAD | 5.34% |
2013 FY | -7623.00 CAD | 2.93% |
2013 Q3 | -8053.00 CAD | 73.99% |
2013 Q2 | -30.96 Thousand CAD | -214.0% |
2012 FY | -7853.00 CAD | -102.87% |
2012 Q1 | -64.47 Thousand CAD | -123.54% |
2012 Q4 | -7853.00 CAD | -24.61% |
2012 Q2 | -134.83 Thousand CAD | -109.14% |
2012 Q3 | -6302.00 CAD | 95.33% |
2011 Q2 | 212.84 Thousand CAD | 22.1% |
2011 Q1 | 174.31 Thousand CAD | 232.57% |
2011 Q4 | 273.84 Thousand CAD | 5.69% |
2011 FY | 273.84 Thousand CAD | 422.46% |
2011 Q3 | 259.09 Thousand CAD | 21.73% |
2010 Q4 | 52.41 Thousand CAD | 146.87% |
2010 Q3 | 21.23 Thousand CAD | 118.18% |
2010 FY | 52.41 Thousand CAD | 165.75% |
2010 Q2 | -116.81 Thousand CAD | -1314.27% |
2010 Q1 | 9620.00 CAD | 112.07% |
2009 Q4 | -79.71 Thousand CAD | -187.65% |
2009 FY | -79.71 Thousand CAD | -370.08% |
2009 Q3 | 90.94 Thousand CAD | 17.83% |
2009 Q2 | 77.18 Thousand CAD | 99.25% |
2009 Q1 | 38.73 Thousand CAD | 31.24% |
2008 Q3 | -44.93 Thousand CAD | 0.0% |
2008 FY | 29.51 Thousand CAD | 117.74% |
2008 Q4 | 29.51 Thousand CAD | 165.68% |
2007 FY | -166.36 Thousand CAD | 0.0% |
2007 Q4 | -166.36 Thousand CAD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
China Medicine Corporation | 9.03 Million USD | 85.488% |
DH Enchantment Inc. | 409.44 Thousand USD | -220.201% |
Exlites Holdings International, Inc. | - USD | -Infinity% |
Itonis, Inc. | 909.99 Thousand USD | -44.072% |
One Step Vending Corp. | 247.1 Thousand USD | -430.557% |
MediPal Holdings Corporation | -1.49 Billion USD | 100.088% |
PD-Rx Pharmaceuticals, Inc. | -6.83 Million USD | 119.186% |
Pharmagen, Inc. | 4362.26 USD | -29954.353% |
Suzuken Co., Ltd. | -1.17 Billion USD | 100.112% |